115 related articles for article (PubMed ID: 15621685)
21. Syntheses, chemical and enzymatic stability of new poly(ethylene glycol)-acyclovir prodrugs.
Zacchigna M; Di Luca G; Maurich V; Boccù E
Farmaco; 2002 Mar; 57(3):207-14. PubMed ID: 11989799
[TBL] [Abstract][Full Text] [Related]
22. New biodegradable hydrogels based on an acryloylated polyaspartamide cross-linked by gamma irradiation.
Giammona G; Pitarresi G; Cavallaro G; Spadaro G
J Biomater Sci Polym Ed; 1999; 10(9):969-87. PubMed ID: 10574611
[TBL] [Abstract][Full Text] [Related]
23. Galactosylated micelles for a ribavirin prodrug targeting to hepatocytes.
Craparo EF; Triolo D; Pitarresi G; Giammona G; Cavallaro G
Biomacromolecules; 2013 Jun; 14(6):1838-49. PubMed ID: 23621358
[TBL] [Abstract][Full Text] [Related]
24. Polyaspartamide gadolinium complexes containing sulfadiazine groups as potential macromolecular MRI contrast agents.
Yan GP; Liu ML; Li LY
Bioconjug Chem; 2005; 16(4):967-71. PubMed ID: 16029038
[TBL] [Abstract][Full Text] [Related]
25. Poly(HEMA-Zidovudine) conjugate: a macromolecular pro-drug for improvement in the biopharmaceutical properties of the drug.
Neeraj A; Chandrasekar MJ; Sara UV; Rohini A
Drug Deliv; 2011 May; 18(4):272-80. PubMed ID: 21110710
[TBL] [Abstract][Full Text] [Related]
26. Ribavirin conjugated with lactosaminated poly-L-lysine: selective delivery to the liver and increased antiviral activity in mice with viral hepatitis.
Di Stefano G; Colonna FP; Bongini A; Busi C; Mattioli A; Fiume L
Biochem Pharmacol; 1997 Aug; 54(3):357-63. PubMed ID: 9278094
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the interaction and drug release from alpha,beta-polyaspartamide derivatives to a biomembrane model.
Castelli F; Messina C; Craparo EF; Mandracchia D; Pitarresi G
Drug Deliv; 2005; 12(6):357-66. PubMed ID: 16253951
[TBL] [Abstract][Full Text] [Related]
28. Antitumor activity and toxicological properties of doxorubicin conjugated to [alpha],[beta]-poly[(2-hydroxyethyl)-L-aspartamide] administered intraperitoneally in mice.
Cheng C; Xue W; Diao H; Xia S; Zuo L; He A; Gao F; Huang Z; Chen J; Zhang J
Anticancer Drugs; 2010 Apr; 21(4):362-71. PubMed ID: 20468087
[TBL] [Abstract][Full Text] [Related]
29. Preparation and antitumor activity of a polymeric derivative of methotrexate.
Zhou G; Cheng X; Wu S; Jiang X; Shi X; Chen J; Zhang J; Zhao J
Am J Med Sci; 2012 Oct; 344(4):294-9. PubMed ID: 22885620
[TBL] [Abstract][Full Text] [Related]
30. In-situ forming gel-like depot of a polyaspartamide-polylactide copolymer for once a week administration of sulpiride.
Fiorica C; Palumbo FS; Pitarresi G; Giorgi M; Calascibetta F; Giammona G
J Pharm Pharmacol; 2015 Jan; 67(1):78-86. PubMed ID: 25243336
[TBL] [Abstract][Full Text] [Related]
31. Modulation of physical and biological properties of a composite PLLA and polyaspartamide derivative obtained via thermally induced phase separation (TIPS) technique.
Carfì Pavia F; Palumbo FS; La Carrubba V; Bongiovì F; Brucato V; Pitarresi G; Giammona G
Mater Sci Eng C Mater Biol Appl; 2016 Oct; 67():561-569. PubMed ID: 27287155
[TBL] [Abstract][Full Text] [Related]
32. In situ growth of a C-terminal interferon-alpha conjugate of a phospholipid polymer that outperforms PEGASYS in cancer therapy.
Hu J; Wang G; Zhao W; Gao W
J Control Release; 2016 Sep; 237():71-7. PubMed ID: 27393654
[TBL] [Abstract][Full Text] [Related]
33. Macromolecular prodrugs. IX. Synthesis of polymer-fenoprofen conjugates.
Zovko M; Zorc B; Lovrek M; Boneschans B
Int J Pharm; 2001 Oct; 228(1-2):129-38. PubMed ID: 11576775
[TBL] [Abstract][Full Text] [Related]
34. PHEA-PLA biocompatible nanoparticles by technique of solvent evaporation from multiple emulsions.
Cavallaro G; Craparo EF; Sardo C; Lamberti G; Barba AA; Dalmoro A
Int J Pharm; 2015 Nov; 495(2):719-27. PubMed ID: 26410757
[TBL] [Abstract][Full Text] [Related]
35. Targeting of antiviral drugs to T4-lymphocytes. Anti-HIV activity of neoglycoprotein-AZTMP conjugates in vitro.
Molema G; Jansen RW; Pauwels R; de Clercq E; Meijer DK
Biochem Pharmacol; 1990 Dec; 40(12):2603-10. PubMed ID: 1979734
[TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo activity of 1-O-hexadecylpropanediol-3-phospho-ganciclovir and 1-O-hexadecylpropanediol-3-phospho-penciclovir in cytomegalovirus and herpes simplex virus infections.
Hostetler KY; Rybak RJ; Beadle JR; Gardner MF; Aldern KA; Wright KN; Kern ER
Antivir Chem Chemother; 2001 Jan; 12(1):61-70. PubMed ID: 11437323
[TBL] [Abstract][Full Text] [Related]
37. Galactosylated polymeric carriers for liver targeting of sorafenib.
Craparo EF; Sardo C; Serio R; Zizzo MG; Bondì ML; Giammona G; Cavallaro G
Int J Pharm; 2014 May; 466(1-2):172-80. PubMed ID: 24607205
[TBL] [Abstract][Full Text] [Related]
38. Kinetics of dopamine release from poly(aspartamide)-based prodrugs.
Juriga D; Laszlo I; Ludanyi K; Klebovich I; Chae CH; Zrinyi M
Acta Biomater; 2018 Aug; 76():225-238. PubMed ID: 29940369
[TBL] [Abstract][Full Text] [Related]
39. Macromolecular prodrugs based on synthetic polyaminoacids: drug delivery and drug targeting in antitumor therapy.
Cavallaro G; Pitarresi G; Giammona G
Curr Top Med Chem; 2011; 11(18):2382-9. PubMed ID: 21671863
[TBL] [Abstract][Full Text] [Related]
40. Self-aggregates of poly(2-hydroxyethyl aspartamide) copolymers loaded with methotrexate by physical and chemical entrapments.
Kang H; Kim JD; Han SH; Chang IS
J Control Release; 2002 May; 81(1-2):135-44. PubMed ID: 11992686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
